4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-24-000196
Chief Legal Officer sold 3,650 shares at $25.45 ($92,893)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Levine Mark S. Chief Legal Officer | 2024-11-20 | Sale | −3,650 | $25.45 | $92,893 | 319,228 | D |
| Open-market sales · 3,650 sh · avg $25.45 · $92,893 | |||||||
Loading xslF345X05/wk-form4_1732309949.xml…